These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25957993)
1. Interactive effects of citalopram and serotonin transporter genotype on neural correlates of response inhibition and attentional orienting. Fischer AG; Endrass T; Goebel I; Reuter M; Montag C; Kubisch C; Ullsperger M Neuroimage; 2015 Aug; 116():59-67. PubMed ID: 25957993 [TBL] [Abstract][Full Text] [Related]
2. Serotonin reuptake inhibitors and serotonin transporter genotype modulate performance monitoring functions but not their electrophysiological correlates. Fischer AG; Endrass T; Reuter M; Kubisch C; Ullsperger M J Neurosci; 2015 May; 35(21):8181-90. PubMed ID: 26019334 [TBL] [Abstract][Full Text] [Related]
3. Allelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network. Ma Y; Li B; Wang C; Zhang W; Rao Y; Han S Br J Psychiatry; 2015 May; 206(5):385-92. PubMed ID: 25745133 [TBL] [Abstract][Full Text] [Related]
4. Serotonergic Regulation and Cognition after Stroke: The Role of Antidepressant Treatment and Genetic Variation. Damsbo AG; Kraglund KL; Buttenschøn HN; Johnsen SP; Andersen G; Mortensen JK Cerebrovasc Dis; 2019; 47(1-2):72-79. PubMed ID: 30844812 [TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter polymorphism alters citalopram effects on human pain responses to physical pain. Ma Y; Wang C; Luo S; Li B; Wager TD; Zhang W; Rao Y; Han S Neuroimage; 2016 Jul; 135():186-96. PubMed ID: 27132044 [TBL] [Abstract][Full Text] [Related]
6. Drinking histories in alcohol-use-disordered youth: preliminary findings on relationships to platelet serotonin transporter expression with genotypes of the serotonin transporter. Dawes MA; Roache JD; Javors MA; Bergeson SE; Richard DM; Mathias CW; Ait-Daoud N; Dougherty DM; Johnson BA J Stud Alcohol Drugs; 2009 Nov; 70(6):899-907. PubMed ID: 19895766 [TBL] [Abstract][Full Text] [Related]
7. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: preliminary findings from a randomised, crossover fMRI study. Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH Aust N Z J Psychiatry; 2014 Dec; 48(12):1115-25. PubMed ID: 24810870 [TBL] [Abstract][Full Text] [Related]
8. Effects of serotonin transporter promoter polymorphisms on serotonin function. Smith GS; Lotrich FE; Malhotra AK; Lee AT; Ma Y; Kramer E; Gregersen PK; Eidelberg D; Pollock BG Neuropsychopharmacology; 2004 Dec; 29(12):2226-34. PubMed ID: 15354180 [TBL] [Abstract][Full Text] [Related]
9. Impact of 5-HTTLPR on SSRI serotonin transporter blockade during emotion regulation: A preliminary fMRI study. Outhred T; Das P; Dobson-Stone C; Felmingham KL; Bryant RA; Nathan PJ; Malhi GS; Kemp AH J Affect Disord; 2016 May; 196():11-9. PubMed ID: 26896742 [TBL] [Abstract][Full Text] [Related]
10. Augmentation of serotonin enhances pleasant and suppresses unpleasant cortical electrophysiological responses to visual emotional stimuli in humans. Kemp AH; Gray MA; Silberstein RB; Armstrong SM; Nathan PJ Neuroimage; 2004 Jul; 22(3):1084-96. PubMed ID: 15219580 [TBL] [Abstract][Full Text] [Related]
11. Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Eichhammer P; Langguth B; Wiegand R; Kharraz A; Frick U; Hajak G Psychopharmacology (Berl); 2003 Mar; 166(3):294-7. PubMed ID: 12563545 [TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. Kronenberg S; Apter A; Brent D; Schirman S; Melhem N; Pick N; Gothelf D; Carmel M; Frisch A; Weizman A J Child Adolesc Psychopharmacol; 2007 Dec; 17(6):741-50. PubMed ID: 18315446 [TBL] [Abstract][Full Text] [Related]
13. Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics. Javors MA; Seneviratne C; Roache JD; Ait-Daoud N; Bergeson SE; Walss-Bass MC; Akhtar FZ; Johnson BA Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):7-13. PubMed ID: 15610939 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of the selective serotonin reuptake inhibitor citalopram: A combined SPECT and phMRI study. Schrantee A; Solleveld MM; Schwantje H; Bruin WB; Mutsaerts HM; Adriaanse SM; Lucassen P; Booij J; Reneman L J Psychopharmacol; 2019 Jun; 33(6):660-669. PubMed ID: 30887865 [TBL] [Abstract][Full Text] [Related]
16. Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking? Johnson BA; Javors MA; Roache JD; Seneviratne C; Bergeson SE; Ait-Daoud N; Dawes MA; Ma JZ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):209-16. PubMed ID: 17950969 [TBL] [Abstract][Full Text] [Related]
17. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder. Won ES; Chang HS; Lee HY; Ham BJ; Lee MS Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326 [TBL] [Abstract][Full Text] [Related]
18. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Anderson GM; Gutknecht L; Cohen DJ; Brailly-Tabard S; Cohen JH; Ferrari P; Roubertoux PL; Tordjman S Mol Psychiatry; 2002; 7(8):831-6. PubMed ID: 12232775 [TBL] [Abstract][Full Text] [Related]